Key facts
- This page summarizes Eric Dobmeier's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jun 2021, 19:07.
Eric Dobmeier - 08 Jun 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Reporting relationship
- Director
- Issuer ticker
- ATRA
- Reported as of
- 08 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2021, 19:07:20 UTC
- Prior SEC filing
- 18 May 2021
- Next SEC filing
- 15 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Tucker, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Dobmeier filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 09 Jun 2021.
Change
- Previous filing in this sequence was filed on 18 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATRA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +11,000
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 39,000
- Date
- 08 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATRA
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +17,500
- Change %
- Price
- $0.000000
- Shares after
- 17,500
- Date
- 08 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,500
- Exercise price
- $13.80
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units shall vest on the earlier of June 8, 2022 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
Footnote F2
The option shall vest on the earlier of June 8, 2022 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.